Literature DB >> 31800531

Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury.

Ji-Song Liu1, Juan Du2, Xiu Cheng3, Xiang-Zhou Zhang4, Yong Li4, Xu-Lin Chen1.   

Abstract

BACKGROUND: The aim of this study was to investigate the molecular mechanism of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes (hUCMSC-Exos) in regulating burn-induced acute lung injury (ALI).
METHODS: In this study, we initially isolated exosomes from hUCMSCs and identified them by transmission electron microscopy. The expression of the protein markers CD9 and CD63 in the exosomes was determined by western blot analysis. The expression of miR-451 in the hUCMSC-Exos was determined by qRT-PCR. The levels of TNF-α, IL-1β, and IL-6 in lung tissues and serum as well as the levels of malondialdehyde, myeloperoxidase, superoxide dismutase in lung tissues were detected by ELISA. Hematoxylin-eosin stain was used to observe the morphological changes of lung tissues after burn. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assays were performed to detect apoptosis in lung tissues after burn. The expression of proteins related to the Toll-like receptor 4 (TLR4)/NF-κB signaling pathway in lung tissues after burn was analyzed by western blotting.
RESULTS: Our results showed that hUCMSC-Exos successfully decreased TNF-α, IL-1β, and IL-6 levels in rats after burn, and this reduction was reversed when the miR-451 expression in the hUCMSC-Exo group was inhibited. HUCMSC-Exo-derived miR-451 improves ALI via the TLR4/NF-κB pathway.
CONCLUSION: We demonstrated that exosomes derived from hUCMSCs mediate miR-451 to attenuate burn-induced ALI.

Entities:  

Year:  2019        PMID: 31800531     DOI: 10.1097/JCMA.0000000000000189

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  19 in total

Review 1.  Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.

Authors:  Wendi Wang; Wei Lei; Lina Jiang; Siqi Gao; Shijun Hu; Zi-Gang Zhao; Chun-Yu Niu; Zhen-Ao Zhao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

Review 2.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

Review 3.  Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?

Authors:  Kasra Khalaj; Rebeca Lopes Figueira; Lina Antounians; Giuseppe Lauriti; Augusto Zani
Journal:  J Extracell Vesicles       Date:  2020-08-06

4.  Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.

Authors:  Carl Randall Harrell; Biljana Popovska Jovicic; Valentin Djonov; Vladislav Volarevic
Journal:  Anal Cell Pathol (Amst)       Date:  2020-11-20       Impact factor: 2.916

Review 5.  What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?

Authors:  Qixin Xie; Rui Liu; Jia Jiang; Jing Peng; Chunyan Yang; Wen Zhang; Sheng Wang; Jing Song
Journal:  Stem Cell Res Ther       Date:  2020-12-01       Impact factor: 6.832

6.  MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance.

Authors:  Frederike Butz; Ann-Kathrin Eichelmann; George C Mayne; Tingting Wang; Isabell Bastian; Karen Chiam; Shashikanth Marri; Pamela J Sykes; Bas P Wijnhoven; Eelke Toxopeus; Michael Z Michael; Christos S Karapetis; Richard Hummel; David I Watson; Damian J Hussey
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

7.  Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.

Authors:  Meng-Meng Shi; Qing-Yuan Yang; Antoine Monsel; Jia-Yang Yan; Cheng-Xiang Dai; Jing-Ya Zhao; Guo-Chao Shi; Min Zhou; Xue-Mei Zhu; Su-Ke Li; Ping Li; Jing Wang; Meng Li; Ji-Gang Lei; Dong Xu; Ying-Gang Zhu; Jie-Ming Qu
Journal:  J Extracell Vesicles       Date:  2021-08-14

Review 8.  A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.

Authors:  Soudeh Moghadasi; Marischa Elveny; Heshu Sulaiman Rahman; Wanich Suksatan; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Alexei Valerievich Yumashev; Siavash Shariatzadeh; Roza Motavalli; Farahnaz Behzad; Faroogh Marofi; Ali Hassanzadeh; Yashwant Pathak; Mostafa Jarahian
Journal:  J Transl Med       Date:  2021-07-12       Impact factor: 5.531

Review 9.  Novel Applications of Mesenchymal Stem Cell-derived Exosomes for Myocardial Infarction Therapeutics.

Authors:  Sho Joseph Ozaki Tan; Juliana Ferreria Floriano; Laura Nicastro; Costanza Emanueli; Francesco Catapano
Journal:  Biomolecules       Date:  2020-05-02

10.  MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy.

Authors:  Xuxia Wei; Xiaomeng Yi; Haijin Lv; Xin Sui; Pinglan Lu; Lijuan Li; Yuling An; Yang Yang; Huimin Yi; Guihua Chen
Journal:  Cell Death Dis       Date:  2020-08-19       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.